BANK OF AMERICA CORP /DE/ - ACASTI PHARMA INC ownership

ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 25 filers reported holding ACASTI PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ACASTI PHARMA INC
ValueSharesWeighting
Q2 2021$1,000
-50.0%
2,5000.0%0.00%
Q1 2021$2,000
+100.0%
2,5000.0%0.00%
Q4 2020$1,0000.0%2,500
-44.4%
0.00%
Q3 2020$1,000
-50.0%
4,5000.0%0.00%
Q2 2020$2,0000.0%4,5000.0%0.00%
Q1 2020$2,000
-99.0%
4,500
-94.5%
0.00%
Q4 2019$199,000
+2387.5%
81,324
+1862.0%
0.00%
Q3 2019$8,000
-74.2%
4,145
-89.0%
0.00%
Q4 2018$31,00037,7710.00%
Other shareholders
ACASTI PHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Virtu Financial LLC 145,202$137,0000.01%
Perceptive Advisors 186,559$176,0000.01%
INTACT INVESTMENT MANAGEMENT INC. 88,990$106,0000.00%
WELLS FARGO & COMPANY/MN 8,630$8,0000.00%
TORONTO DOMINION BANK 7$00.00%
DEUTSCHE BANK AG\ 252,603$238,0000.00%
MORGAN STANLEY 40,000$38,0000.00%
BANK OF MONTREAL /CAN/ 212$00.00%
Citadel Advisors 25,980$24,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 559,835$528,0000.00%
View complete list of ACASTI PHARMA INC shareholders